Sum­it­o­mo to lay off about 400 em­ploy­ees, reshuf­fle ex­ecs in North Amer­i­ca as sales dis­ap­points

Sum­it­o­mo Phar­ma is lay­ing off an­oth­er 400 em­ploy­ees in North Amer­i­ca and shak­ing up its lead­er­ship team af­ter three of its drugs failed to hit ex­pect­ed sales tar­gets. Myr­tle Pot­ter, pres­i­dent and CEO of Sum­it­o­mo Phar­ma Amer­i­ca, will be de­part­ing at the end of March.

The Japan­ese com­pa­ny had al­ready re­or­ga­nized its North Amer­i­can unit once in 2023, cut­ting 500 jobs in the process. But the low­er-than-ex­pect­ed growth — com­ing in be­low pro­jec­tions in its 2027 busi­ness plan — prompt­ed it to stream­line its or­ga­ni­za­tion­al op­er­a­tions fur­ther, ac­cord­ing to the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER